GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma.
Zirngibl F, Ivasko SM, Grunewald L, Klaus A, Schwiebert S, Ruf P, Lindhofer H, Astrahantseff K, Andersch L, Schulte JH, Lode HN, Eggert A, Anders K, Hundsdoerfer P, Künkele A.
Zirngibl F, et al. Among authors: lindhofer h.
J Immunother Cancer. 2021 Jul;9(7):e002923. doi: 10.1136/jitc-2021-002923.
J Immunother Cancer. 2021.
PMID: 34285106
Free PMC article.